Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suaeda fruticosa ethanolic extract is a botanical research compound derived from the halophytic medicinal plant *Suaeda fruticosa* (shrubby seablite), belonging to the family Amaranthaceae. The extract is characterized by a complex mixture of bioactive phytoconstituents, including phytol, thymol, n-hexadecanoic acid, farnesol, and 1-heptacosanol, alongside various phenolic compounds and flavonoids. Preclinical research in animal models has demonstrated that the extract possesses significant anti-inflammatory, antioxidant, and gastroprotective properties. Its mechanism of action involves the modulation of multiple inflammatory signaling pathways, specifically the down-regulation of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and the inhibition of NF-κB and COX-2 expression. Additionally, it promotes the up-regulation of the anti-inflammatory cytokine IL-10 and enhances antioxidant defenses by increasing glutathione (GSH) levels. It is primarily investigated for its potential therapeutic application in ulcerative colitis, rheumatoid arthritis, and gastric ulcers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on suaeda fruticosa ethanolic extract.